Global Digital Telepathology Market Overview
According to SPER Market Research, the Global Digital Telepathology Market is estimated to reach USD 2.19 billion by 2032 with a CAGR of 9.6%.
Digital telepathology, which can be used for remote primary diagnoses, quality control, second opinion consultations, research, and educational reasons, is the practice of remote pathology employing telecommunication links to permit the electronic transfer of digital pathology pictures. By enabling quick connections with experts, digital telepathology helps an increasing number of laboratories around the world provide pathology services. The digital telepathology market is expected to have considerable growth during the projected period. Telepathology is also utilized to improve the efficiency of pathology services between institutions that are less than a mile away.
The market for digital telepathology is expanding as a result of the high costs involved with conventional diagnostics. Growing Clinical Need for Telepathology Acceptance to Enhance Current Patient Diagnostic Imaging Events. Pathologists and pathologists-in-training now have access to a range of materials thanks to this imaging technology that will enable them to continue providing patient care remotely, cooperate, and enhance online learning. This paradigm shift will have an impact on how we conduct our daily business in the post-pandemic period as well as how we teach pathology electronically in the future. It may even lead to changes in the rules that control the use and approval of digital pathology systems for diagnostic purposes.
Impact of COVID-19 on the Global Digital Telepathology Market
Years ago, digital pathology was created to enable pathologists to remotely work together on cases and increase the precision of diagnostic procedures by exchanging digital pictures among laboratories. Due to the US Food and Drug Administration's (FDA) and the Centers for Medicare & Medicaid Services' (CMS) stringent federal restrictions, the US fell behind the majority of developed nations in terms of adopting digital pathology prior to the COVID-19 pandemic. To accommodate the needs of the pandemic response, the FDA loosened certain of its standards for approving and validating digital pathology-related technology. In a similar vein, the CMS eliminated onerous CLIA regulations, enabling pathologists to work remotely with digital pathology tools. As a result, the COVID-19 pandemic hastened the widespread adoption of digital pathology for remote diagnosis.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Type, By Application, By End User
|
| Regions covered | Asia-Pacific, Europe, Middle East and Africa, North America, Latin America |
| Companies Covered | GE Healthcare, Glencoe Software, Inspirata,
Kanteron Systems, Leica Biosystems, MikroSkan Technologies Inc., Olympus
Corporation, OptraSCAN, Philips Healthcare, Ventana Medical Systems Inc.
|
Target Audience-
- Business Consulting Firms
- Government Organizations
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Software and Hardware Companies
- Others
Global Digital Telepathology Market Segmentation:
1. By Type:
2. By Application:
- Diagnosis
- Education
- Research
- Others
3. By End User:
- Academic Institutes
- Diagnostic Centers and Pathology Clinics
- Hospital
- Pharmaceutical and Biotech Companies
4. By Region:
- Asia-Pacific
- Europe
- Middle East & Africa
- North America
- Latin America
Key Topics Covered in the Report:- Size of Global Digital Telepathology Market (FY’2019-FY’2032)
- Overview of Global Digital Telepathology Market
- Segmentation of Global Digital Telepathology Market By Type (Education, Medical, Other)
- Segmentation of Global Digital Telepathology Market By Application (Diagnosis, Education, Research, Others)
- Segmentation of Global Digital Telepathology Market By End User (Academic Institutes, Diagnostic Centers and Pathology Clinics, Hospital, Pharmaceutical and Biotech Companies, Research Organizations, Others)
- Statistical Snap of Global Digital Telepathology Market
- Growth Analysis of Global Digital Telepathology Market
- Problems and Challenges in Global Digital Telepathology Market
- Competitive Landscape in the Global Digital Telepathology Market
- Impact of COVID-19 and Demonetization on Global Digital Telepathology Market
- Details on Recent Investment in Global Digital Telepathology Market
- Competitive Analysis of Global Digital Telepathology Market
- Major Players in the Global Digital Telepathology Market
- SWOT Analysis of Global Digital Telepathology Market
- Global Digital Telepathology Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1.Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Digital Telepathology Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1Strengths
5.1.2Weaknesses
5.1.3Opportunities
5.1.4Threats
5.2. PESTEL analysis
5.2.1Political landscape
5.2.2Economic landscape
5.2.3Social landscape
5.2.4Technological landscape
5.2.5Environmental landscape
5.2.6Legal landscape
5.3. PORTER’S five forces analysis
5.3.1Bargaining power of suppliers
5.3.2Bargaining power of Buyers
5.3.3Threat of Substitute
5.3.4Threat of new entrant
5.3.5Competitive rivalry
5.4. Heat map analysis
6.Competitive Landscape
6.1Global Digital Telepathology Manufacturing Base Distribution, Sales Area, Product Type
6.2Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Digital Telepathology Market
7.Global Digital Telepathology Market, By Type, 2019-2032 (USD Million)
7.1 Education
7.2 Medical
7.3 Other
8.Global Digital Telepathology Market, By Application, 2019-2032 (USD Million)
8.1 Diagnosis
8.2 Education
8.3 Research
8.4 Others
9.Global Digital Telepathology Market, By End User, 2019-2032 (USD Million)
9.1 Academic Institutes
9.2 Diagnostic Centers and Pathology Clinics
9.3 Hospital
9.4 Pharmaceutical and Biotech Companies
9.5 Research Organizations
9.6 Others
10. Global Digital Telepathology Market, By Region, 2019-2032 (USD Million)
10.1 Global Digital Telepathology Market and Market Share by Region (2019-2025)
10.2 Global Digital Telepathology Market and Market Share by Region (2026-2032)
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Europe
10.4.1 France
10.4.2 Germany
10.4.3 Italy
10.4.4 Spain
10.4.5 United Kingdom
10.4.6 Rest of Europe
10.5Middle East and Africa
10.5.1Kingdom of Saudi Arabia
10.5.2United Arab Emirates
10.5.3Rest of Middle East & Africa
10.6North America
10.6.1Canada
10.6.2Mexico
10.6.3United States
10.7Latin America
10.7.1Argentina
10.7.2Brazil
10.7.3Rest of Latin America
11. Company Profiles
11.1GE Healthcare
11.1.1Company details
11.1.2Financial outlook
11.1.3Product summary
11.1.4Recent developments
11.2Glencoe Software
11.2.1Company details
11.2.2Financial outlook
11.2.3Product summary
11.2.4Recent developments
11.3Inspirata
11.3.1Company details
11.3.2Financial outlook
11.3.3Product summary
11.3.4Recent developments
11.4Kanteron Systems
11.4.1Company details
11.4.2Financial outlook
11.4.3Product summary
11.4.4Recent developments
11.5Leica Biosystems
11.5.1Company details
11.5.2Financial outlook
11.5.3Product summary
11.5.4Recent developments
11.6MikroSkan Technologies Inc.
11.6.1Company details
11.6.2Financial outlook
11.6.3Product summary
11.6.4Recent developments
11.7Olympus Corporation
11.7.1Company details
11.7.2Financial outlook
11.7.3Product summary
11.7.4Recent developments
11.8OptraSCAN
11.8.1Company details
11.8.2Financial outlook
11.8.3Product summary
11.8.4Recent developments
11.9Philips Healthcare
11.9.1Company details
11.9.2Financial outlook
11.9.3Product summary
11.9.4Recent developments
11.10Ventana Medical Systems Inc.
11.10.1Company details
11.10.2Financial outlook
11.10.3Product summary
11.10.4Recent developments
12. List of Abbreviations
13. Reference Links
14. Conclusion
15. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
